Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-06

Clinical Trial Update: Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the role of an aromatase inhibitor to enhance ovulation in poor responders undergoing induction with a short antagonist protocol for IC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Minia University | Conditions: Infertility Indicated for ICSI | Phase 4 | Status: COMPLETED